{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:44:38Z","timestamp":1781174678501,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.cancergencyto.2010.01.018","type":"journal-article","created":{"date-parts":[[2010,4,24]],"date-time":"2010-04-24T08:25:36Z","timestamp":1272097536000},"page":"56-61","source":"Crossref","is-referenced-by-count":12,"title":["Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation"],"prefix":"10.1016","volume":"199","author":[{"given":"Gaku","family":"Oshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.01.018_bib1","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2014advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib3","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","article-title":"Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction)","volume":"88","author":"Pane","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib4","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1038\/sj.onc.1206194","article-title":"BCR\/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations","volume":"21","author":"Pane","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2257.2002.00413.x","article-title":"BCR\/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML)","volume":"24","author":"Arana-Trejo","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2141.2004.05119.x","article-title":"Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukaemia patient with micro-BCR-ABL (e19a2) transcript","volume":"126","author":"Ito","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.trsl.2006.07.002","article-title":"Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR","volume":"148","author":"Goh","year":"2006","journal-title":"Transl Res"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib8","first-page":"3192","article-title":"Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR\/ABL fusion protein","volume":"55","author":"Wada","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2141.1996.d01-1798.x","article-title":"Elevated platelet count features the variant type of BCR\/ABL junction in chronic myelogenous leukaemia","volume":"94","author":"Yamagata","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib10","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V89.8.3064","article-title":"BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia","volume":"89","author":"Wilson","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1046\/j.1365-2141.1998.01098.x","article-title":"P230 BCR\/ABL protein may be associated with an acute leukaemia phenotype","volume":"103","author":"Haskovec","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib12","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.leu.2401055","article-title":"Chronic myeloid leukemia with e19a2 (c3a2) BCR\/ABL fusion junction\u2013is it truly a benign disease?","volume":"12","author":"How","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bmt.1702412","article-title":"An accelerrated-phase CML patient with e19a2 junction of BCR\/ABL gene \u2014 the first case of transplanted CML with micro bcr","volume":"25","author":"Polak","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib14","first-page":"320","article-title":"p230 does not always predict a mild clinical course in myeloid malignancies: e19a2 bcr\/abl fusion transcript with additional chromosome abnormalities in a patient with acute monoblastic leukemia (M5a)","volume":"86","author":"Bernasconi","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib15","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/sj.leu.2402292","article-title":"The e19a2 BCR\/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type","volume":"15","author":"Bertorelle","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib16","article-title":"Typical chronic myelogenous leukemia with e19a2 BCR\/ABL transcript. Report of two cases","volume":"87","author":"Martinez-Lopez","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2141.2002.03570.x","article-title":"Blast crisis of Philadelphia chromosome-positive chronic myeloid leukaemia carrying micro-bcr breakpoint (e19a2 and e191a)","volume":"118","author":"Ohsaka","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib18","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cncr.10490","article-title":"Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR\/ABL mRNA and undetectable BCR\/ABL protein may predict an indolent course","volume":"94","author":"Verstovsek","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib19","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/sj.leu.2402600","article-title":"e19a2-positive chronic myeloid leukaemia with BCR exon e16-deleted transcripts","volume":"16","author":"Wang","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/sj.leu.2403454","article-title":"Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts","volume":"18","author":"Lee","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.leu.2403761","article-title":"Identification of e19a2 BCR-ABL fusions (mu-BCR breakpoints) at the DNA level by ligation-mediated PCR","volume":"19","author":"Boeckx","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jcp.2005.029595","article-title":"e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases","volume":"59","author":"Mondal","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hon.822","article-title":"First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts","volume":"25","author":"Andrikovics","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cancergencyto.2007.04.013","article-title":"A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript","volume":"176","author":"Li","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.leukres.2007.03.001","article-title":"Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML","volume":"32","author":"Popovici","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbrc.2004.05.113","article-title":"The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR\/ABL fusion kinase","volume":"319","author":"Yamamoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.hoc.2004.03.012","article-title":"Clonal evolution in chronic myelogenous leukemia","volume":"18","author":"Cortes","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/blood.V72.1.294.294","article-title":"Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia","volume":"72","author":"Sokal","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0165-4608(03)00283-8","article-title":"Secondary chromosomal changes in 34 Philadelphia-chromosome-positive chronic myelocytic leukemia patients from the Mexican West","volume":"148","author":"Meza Espinoza","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-4608(93)90216-9","article-title":"Double t(1;7)(p36;p11) in a megakaryocytic crisis of chronic myelogenous leukemia with variant t(5;9;22)","volume":"65","author":"Hirata","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cancergencyto.2003.07.009","article-title":"Secondary near-tetraploidy with double der(15)t(15;17) in acute promyelocytic leukemia in relapse","volume":"149","author":"Morita","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.V61.1.71.71","article-title":"Near-tetraploid clones in acute leukemia","volume":"61","author":"Testa","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cancergencyto.2006.10.013","article-title":"Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies","volume":"173","author":"Adeyinka","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2007.01.013","article-title":"Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?","volume":"176","author":"Lessard","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2007.10.024","article-title":"Limiting the proliferation of polyploid cells","volume":"131","author":"Ganem","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2010.01.018_bib37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1532\/IJH97.05186","article-title":"Oral administration of imatinib to P230 BCR\/ABL-expressing transgenic mice changes clones with high BCR\/ABL complementary DNA expression into those with low expression","volume":"84","author":"Inami","year":"2006","journal-title":"Int J Hematol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:46:31Z","timestamp":1591231591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0165460810000452"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.01.018","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}